SMS Pharmaceuticals shareholding pattern

SMSPHARMA

424.3

14.05 (3.42%)
Last updated on 20 May, 2026 | 15:51 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

SMS Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
  • 2018-19
  • 2019-20
Total Promoters
Segment
Percent

Total Promoters

67.29%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.56%

Domestic Institutional Investors

0%

Retail

32.15%

Others

0%

Total Promoters
MAR '20
68.69%
JUN '20
67.29%
SEP '20
67.29%
DEC '20
67.29%

Summary

SMS Pharmaceuticals share holding pattern reports the following shareholding: SMS Pharmaceuticals Total Promoters is at 68.07%, Mutual Fund at 2.96%, Insurance at 0.00%, Foreign Institutional Investors at 0.31%, Domestic Institutional Investors at 0.05%, and Retail at 28.61%. This breakdown provides a quick snapshot of ownership distribution for SMS Pharmaceuticals share holding pattern in 2026-27.

SMS Pharmaceuticals FAQs

As of 05-2026, the promoter shareholding in SMS Pharmaceuticals stands at 68.07% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of SMS Pharmaceuticals is 0.31% and 0.05% respectively.

The retail shareholding of the SMS Pharmaceuticals is 28.61%.

Changes in shareholding patterns of SMS Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of SMS Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost